Do not trust the product
Side effects are rare and typically mild, such as slight tingling or temporary redness after application
Participants were randomly assigned in a ratio of 21:3:3:7 to receive the combination of semaglutide at a dose of 2.4 mg and cagrilintide at a dose of 2.4 mg, semaglutide alone at a dose of 2.4 mg, cagrilintide alone at a dose of 2.4 mg, or placebo, plus lifestyle interventions for all groups
Whatever route you choose, the quality of the compound and the guidance of a licensed clinician are not negotiable
(In essence, FOXO4 holds p53 so it cannot execute the death program)
A higher blood level is not the same as a health benefit A trial can demonstrate absorption or a biomarker increase without proving that participants feel better, function better, avoid disease, or live longer